Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke

BACKGROUND: Sovateltide (IRL-1620, PMZ-1620), an endothelin-B receptor agonist, has been previously shown to increase cerebral blood flow, have anti-apoptotic activity and produce neurovascular remodeling when administered intravenously following acute cerebral ischemic stroke in rats. Its safety an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:CNS Drugs
Egile Nagusiak: Gulati, Anil, Agrawal, Nilesh, Vibha, Deepti, Misra, U. K., Paul, Birinder, Jain, Dinesh, Pandian, Jeyaraj, Borgohain, Rupam
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2021
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7872992/
https://ncbi.nlm.nih.gov/pubmed/33428177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-020-00783-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak